Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Decline Accept
Home › Insider trades › Koru Medical Systems › Director received an award of 2,581 KRMD shares
Why it stands out Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
All the details
Dates, kept separate
Transaction date Dec 31, 2025
Reporting period Not applicable
Filed with the SEC Jan 5, 2026 Director Indirect holding Grant / award
Context Classification grant award
Code A — grant or award
Planned / mechanical clue None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
Record ID 0001161697-26-000016
Filed / recorded Jan 5, 2026, 9:19 PM UTC
Added to OQRO Oct 8, 2026, 1:45 AM UTC
Data quality Verified: identifiers matched exactly
Issuer KORU Medical Systems, Inc.
Reporting person Joseph M. Jr. Manko
Relationship Director, 10% owner
Table Non-derivative (Table I)
Transaction date Dec 31, 2025
Acquired / disposed Acquired (A)
Shares owned after 5,832.916
Ownership form Indirect — By Horton Capital Partners Fund, LP
Footnotes from the filing See Exhibit 99.1 to this Form 4 for explanation of note (1). See Exhibit 99.1 to this Form 4 for explanation of note (2).
Around the same time Insider filing
Traded Jan 2 · filed 14 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Jan 2 · filed 14 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Jan 2 · filed 4 days later
Compensation award — excluded from discretionary-purchase analysis.
The story around this disclosure Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
Nov 12, 2025 Company filing · Form 8-K · Results Reported its results Nov 19, 2025 Company filing · Form 8-K · Material agreement Signed an important agreement What came next Jan 12, 2026 Company filing · Form 8-K · Results Reported its results Feb 5, 2026 Company filing · Form 8-K · Bylaws or charter Changed its bylaws, charter or fiscal year Mar 12, 2026 Company filing · Form 8-K · Results Reported its results Mar 12, 2026 Company filing · Form 8-K · Executive change Changed a top executive or board member “Linda Tharby, President and Chief Executive Officer of KORU Medical Systems, Inc. (the “Company”), has announced her retirement as Chief Executive Officer effective June 30, 2026 (the “Transition Date”).” Mar 30, 2026 Company filing · Form 8-K · Material agreement, New debt Signed an important agreement, and took on new debt or obligations 